It is half way through Movember, and my moustache is scratchy. I hope you are growing your own, but if not, feel free to support mine here: http://mobro.co/michaelglode
I apologize for not having posted more commentary in the last few months. I am taking a bit of a hiatus to celebrate retirement, but I have a list of topics queued up for blogging that I can share with you. Here are a few, hypertexted so you can think about them:
Ethics of expensive treatments, Earlier salvage radiation therapy, Randomized trial of monitoring, surgery, or radiation, and the patient side effects of each, and what to do about metformin.
Feel free to suggest your own topics that I can research for you and add my thoughts, or vote for one of the above. I hope you and your family have a very peaceful and Happy Thanksgiving!
prost8blog 
Michael:
How about a blog on use of new biomarkers to reduce prostate biopsies and avoid criticism of over diagnosis and over treatment of indolent prostate cancer?
Dr. Glode: I’d be interested in a post regarding the Axumin PET scan. UC Health is making that scan available after the first of the year and my urologic oncologist there agrees that I am a candidate with my biochemical recurrence but not having yet started on ADT treatment. (My PSA has fluctuated up and down for the past two years and is currently on a downward trend which is why I’ve not started ADT, yet.)
Mike, you might address the new Death with Dignity law that just passed in Colorado, as a former oncologist who treated cancer patients.
I vote for 1) metformin and 2) the efficacy of early use of taxotere + ADT for high risk (say stage 3 w/ gleason 4+3 or >) PCa that is not metastatic or hormone resistant
Thank you again for talking with my friend, Tom. It has been much appreciated by him and his family—–
What about an exploration of the current state of immunotherapy treatments, vaccines, T-cells, etc.?
How about an examination of the new Axumin PET scan?
DEar Mike
glad you are enjoying retirement A big hug john
Metformin. It apparently preferentially kills cancerous mesenchymal stem cells, the most untreatable of all cancer cells. Just how does Metformin relate to antioxidants in cancer cells and what would be a non-toxic dose to try?